AIM: Our objective was to report a single-center experience of the management of pituitary tumor apoplexy. PATIENTS AND METHODS: We retrospectively analyzed a series of 44 patients hospitalized for pituitary apoplexy between January 1996 and March 2008 at the Timone Hospital, Marseille, France. RESULTS: Most frequent presenting symptoms were headaches (93%), visual impairment (85%) and vomiting (59%). Hypopituitarism was present at diagnosis in 88% of patients, with a high incidence of corticotroph deficiency (70%). A risk factor was found in 52% of patients, mostly hypertension. Apoplexy occurred in a previously undiagnosed pituitary adenoma in 32/44 cases (73%). The apoplectic event concerned 12 secreting, 27 non-functioning, 4 uncharacterized adenomas and one Rathke's pouch cyst. Nineteen patients underwent surgery within the first month, and one patient had conventional radiotherapy. Twenty-four patients, who had no ophthalmic or neurological signs, were conservatively treated in first intention; among them, 6 received high dose corticosteroids. After a median follow-up of 21 months, there was no significant difference in terms of endocrine or visual recovery between the operated and the conservatively treated groups, nor between patients treated with corticosteroids or not. Panhypopituitarism was observed in 52% of patients, but partial or complete visual recovery was present in the majority of patients (91%), whatever the therapeutic approach. CONCLUSION: The outcome of patients treated with or without surgery for pituitary apoplexy without severe neuro-ophthalmic deficits seems to be identical, pleading for a conservative management of pituitary apoplexy in the absence of visual emergency.
AIM: Our objective was to report a single-center experience of the management of pituitary tumor apoplexy. PATIENTS AND METHODS: We retrospectively analyzed a series of 44 patients hospitalized for pituitary apoplexy between January 1996 and March 2008 at the Timone Hospital, Marseille, France. RESULTS: Most frequent presenting symptoms were headaches (93%), visual impairment (85%) and vomiting (59%). Hypopituitarism was present at diagnosis in 88% of patients, with a high incidence of corticotroph deficiency (70%). A risk factor was found in 52% of patients, mostly hypertension. Apoplexy occurred in a previously undiagnosed pituitary adenoma in 32/44 cases (73%). The apoplectic event concerned 12 secreting, 27 non-functioning, 4 uncharacterized adenomas and one Rathke's pouch cyst. Nineteen patients underwent surgery within the first month, and one patient had conventional radiotherapy. Twenty-four patients, who had no ophthalmic or neurological signs, were conservatively treated in first intention; among them, 6 received high dose corticosteroids. After a median follow-up of 21 months, there was no significant difference in terms of endocrine or visual recovery between the operated and the conservatively treated groups, nor between patients treated with corticosteroids or not. Panhypopituitarism was observed in 52% of patients, but partial or complete visual recovery was present in the majority of patients (91%), whatever the therapeutic approach. CONCLUSION: The outcome of patients treated with or without surgery for pituitary apoplexy without severe neuro-ophthalmic deficits seems to be identical, pleading for a conservative management of pituitary apoplexy in the absence of visual emergency.
Authors: Patrick L Semple; Jacques C De Villiers; Robert M Bowen; M Beatriz S Lopes; Edward R Laws Journal: J Neurosurg Date: 2006-06 Impact factor: 5.115
Authors: Petra Nadja Elsässer Imboden; Nicolas De Tribolet; Alexander Lobrinus; Rolf C Gaillard; Luc Portmann; François Pralong; Fulgencio Gomez Journal: Medicine (Baltimore) Date: 2005-05 Impact factor: 1.889
Authors: D C Bills; F B Meyer; E R Laws; D H Davis; M J Ebersold; B W Scheithauer; D M Ilstrup; C F Abboud Journal: Neurosurgery Date: 1993-10 Impact factor: 4.654
Authors: Scott C Seaman; Mark C Dougherty; Mario Zanaty; Leslie A Bruch; Scott M Graham; Jeremy D W Greenlee Journal: J Neurol Surg B Skull Base Date: 2020-06-19
Authors: N Viola; C Urbani; M Cosottini; A Abruzzese; L Manetti; G Cosentino; G Marconcini; C Marcocci; F Bogazzi; I Lupi Journal: Endocrinol Diabetes Metab Case Rep Date: 2022-06-01
Authors: Ali Abbara; Sophie Clarke; Pei Chia Eng; James Milburn; Devavrata Joshi; Alexander N Comninos; Rozana Ramli; Amrish Mehta; Brynmor Jones; Florian Wernig; Ramesh Nair; Nigel Mendoza; Amir H Sam; Emma Hatfield; Karim Meeran; Waljit Singh Dhillo; Niamh M Martin Journal: Endocr Connect Date: 2018-08-23 Impact factor: 3.335